Prof Arnold Hill
Professor Arnold Hill is one of Ireland’s most distinguished general and breast surgeons, serving as Professor and Chair of Surgery at the Royal College of Surgeons in Ireland (RCSI) and as a Consultant General and Breast Surgeon at Beaumont Hospital. He graduated from University College Dublin in 1988 and completed his basic surgical training in Dublin, before undertaking his further training in London. He then pursued a two-year research and clinical fellowship at the Hospital of the University of Pennsylvania and the New York Hospital/Cornell Medical Centre in the United States. Before returning to Ireland to take up his consultant appointment, Prof Hill completed a Clinical Fellowship in Surgical Oncology at Memorial Sloan Kettering Cancer Centre in New York. This fellowship established his expertise in the surgical management of breast cancer and shaped his career-long commitment to integrating high-quality translational research with clinical practice.
Prof Hill is integral to the Beaumont Hospital Breast Service, which diagnoses and treats over 500 newly diagnosed breast cancers each year. His interests focus on the management of breast cancer, and he has been a central figure in the development of the Beaumont RCSI Cancer Centre as a nationally and internationally recognised institution. He is the National Advisor for Surgical Oncology to the National Cancer Control Programme and is the Chairman of Breast Cancer Ireland, Ireland’s leading voluntary organisation funding breast cancer research.
He has supervised over 50 research fellows through their higher degrees. In close collaboration with Professor Leonie Young and the RCSI Endocrine Oncology Research Group, Prof Hill has co-led a national clinical study, the Proteomics and Molecular Heterogeneity study, established in 2006, registered on ClinicalTrials.gov and sponsored by Cancer Trials Ireland, which has recruited more than 4,000 patients. This study underpins cutting-edge research into breast cancer metastasis, including brain metastasis, for which there remain few targeted therapeutic options.
Prof Hill was instrumental in establishing Ireland’s first National Breast Cancer Tissue BioResource, bringing together leading clinicians and scientists with Cancer Trials Ireland to enable more personalised and targeted treatments. “As a small country we recognise the need for collaborative research in order to gain maximum benefit,” he has said. “This initiative will bring together leading national clinicians and scientists, enabling speedier discoveries and ultimately more effective and personalised treatments for patients.”
Beyond his clinical and research roles, Prof Hill has made a significant impact on surgical education as Dean of Medical Programmes at RCSI. He has championed a new innovative curriculum in RCSI, known as the THEP Program. His work bridges the traditional gap between bench and bedside, and he remains a mentor to a generation of surgical trainees at Beaumont Hospital.
More recently, Professor Hill has launched the first Irish robotic mastectomy program, allowing breast cancer patients and mutation carriers to undergo mastectomy and axillary surgery through a concealed incision and using a minimally invasive approach. With 50 robotic mastectomies performed to date, this innovative approach offers extraordinary benefits for women by allowing them to preserve their skin and nipple-areolar complex and enhancing postoperative sensation. Women no longer need to suffer the psychological trauma of a mastectomy when they can now preserve their own skin and nipple areolar complex of their breast, while benefiting from an abdominoplasty for their reconstruction. The procedure is entirely performed through a 4cm axillary incision.